Last checked at 6 Mar 2014 16:50
6 March 2014 |
Advanced Medical Solutions Group plc
("AMS" or the the "Company")
Exercise of share options and Directors' dealings
Winsford, UK:Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, today announces that Chris Meredith, Chief Executive Officer, has today sold a total of 643,250 ordinary shares of 5p each ("Ordinary Shares") at 114 pence per share. These shares come from a combination of the exercise of certain share incentive schemes and existing Ordinary Shares. Separately, Mr Meredith's SIPP has today acquired 87,719 Ordinary Shares at 114 pence per share.
As a result of these transactions, Mr Meredith's beneficial interest in Ordinary Shares has increased from 1,142,275 to 1,182,938.
A summary of Mr Meredith's beneficial interest in Ordinary Shares and Ordinary Shares under incentive schemes is summarised in the table below.
Number prior to transaction | Number exercised | Shares sold | SIPP purchase | Resultant interest | |
Ordinary Shares | 1,142,275 | - | 47,056 | 87,719 | 1,182,938 |
Long Term Incentive Plan | 1,309,293 | 514,778 | 514,778 | - | 794,515 |
Deferred Share Bonus Plan | 99,325 | 81,416 | 81,416 | - | 17,909 |
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc | Tel: +44 (0) 1606 545508 |
Mary Tavener, Group Finance Director | |
Investec Bank PLC (NOMAD & Broker) | Tel: +44 (0) 20 7597 5970 |
Daniel Adams |